Attention Deficit Hyperactivity Disorder Subtypes and Symptom Response in Adults Treated With Lisdexamfetamine Dimesylate

| June 6, 2012 | 0 Comments

by Greg Mattingly, MD; Richard Weisler, MD; Bryan Dirks, MD; Thomas Babcock, DO; Ben Adeyi, MS; Brian Scheckner, PharmD; and Robert Lasser, MD
Dr. Mattingly is from Washington University School of Medicine in St. Charles, Missouri; Dr. Weisler is from Duke University Medical Center in Durham, North Carolina, and the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Drs. Dirks, Babcock Scheckner, and Lasser and Mr. Adeyi are from Shire Development LLC, Wayne, Pennsylvania.

Innov Clin Neurosci. 2012;9(5–6):22–30

The content you are trying to view is restricted to registered members only.
Membership to Innovations in Clinical Neuroscience is free, so please consider becoming a member today.
Thank you
ICNS Online Editor
Please Login or Register for access.

Tags: ,

Category: Attention Deficit Hyperactivity Disorder, Original Research, Psychiatry

Leave a Reply